In the past 50 years, the tendency to postpone childbearing has spread throughout the developed world. The significant achievements of assisted reproduction technology (ART) created the false impression that childbirth could be safely postponed till late in the usual term of fertility. It has been well-demonstrated that fertility declines dramatically as women age beyond their mid-thirties, with only rare pregnancies beyond the age of 45. Figures released by the Human Fertilization and Embryology authority in 2008 suggest that, over the past 10 years, the average success rate of ART has risen significantly for women younger than 35, from 25 to 35%, but has remained less than 10% for women over 40 (www.hfea.gov.uk). ART merely consists of methods of ensuring fertilization and subsequent transfer of the embryo into the uterus, but has not contributed to the problem of old age and poor responders. Fujii et al have reported the use of low reactive level laser therapy (LLLT) for the treatment of infertility as an adjunct to ART where increased sys- Background and Aims: During the lifespan of the female, biochemical changes occur in the ovarian environment. These changes are brought about by numerous endogenous and exogenous factors, and can have a profound effect on ovarian oocyte quality. Oocytes of poor quality may be the cause of female infertility and are a major obstacle in successful assisted reproductive technologies (ART). We have previously reported on the efficacy of low reactive laser therapy (LLLT) using a GaAlAs diode laser device which emits laser light of 830 nm at an output of 60 mW to improve the poor quality of oocytes as an adjunctive treatment of refractory female infertility. The aim of this study is to assess the LLLT curative effect. Subjects and Method: Eight hundred and fourteen female patients who presented at the Ohshiro clinic for treatment of infertility from July 1 st , 2000 till December, 2009 were enrolled in the analysis. We analyzed the therapeutic frequency and the therapeutic period (the number of menstrual cycles) between pregnant women and non-pregnant women. Results were expressed as means ± standard error of mean. The statistical difference was determined with the two-sided Student's t-test and the Mann-Whitney's U test. Differences with P < 0.05 were considered significant. Result: The mean therapeutic frequency and mean therapeutic period in the subjects who gave birth was 3.3±2.6 times a month and 5.2±6.1 months, respectively, which correspond to the whole oogenesis period. Conclusion: We concluded that laser therapy once per week and a period of 5-6 menstrual cycles might be necessary to gain a good curative effect as the laser effect could last 1 week and the competence of oocytes depends on numerous processes taking place during the whole oogenesis period.
Introduction
In the past 50 years, the tendency to postpone childbearing has spread throughout the developed world. The significant achievements of assisted reproduction technology (ART) created the false impression that childbirth could be safely postponed till late in the usual term of fertility. It has been well-demonstrated that fertility declines dramatically as women age beyond their mid-thirties, with only rare pregnancies beyond the age of 45. Figures released by the Human Fertilization and Embryology authority in 2008 suggest that, over the past 10 years, the average success rate of ART has risen significantly for women younger than 35, from 25 to 35%, but has remained less than 10% for women over 40 (www.hfea.gov.uk) . ART merely consists of methods of ensuring fertilization and subsequent transfer of the embryo into the uterus, but has not contributed to the problem of old age and poor responders. Fujii et al have reported the use of low reactive level laser therapy (LLLT) for the treatment of infertility as an adjunct to ART where increased sys-
ORIGINAL ARTICLES
Taniguchi, Y ET AL. temic blood flow increased the response of the ovary, hence enhanced the response to ART and improved the probability of pregnancy. 1) LLLT has improved the successful rate of ART, but the factors which influence the results have as yet remained unclear. The purpose of this report was to elucidate the points which are important to gain good results from LLLT for the treatment of infertility.
Laser hardware
The Neck Irradiator (Japan Medical Laser Laboratory Corp.) was used for the treatment (Fig. 1) . The Neck Irradiator is a two channel GaAlAs diode laser device which emits continuous wave laser light of 830 nm at an output of 60 mW. Laser light is emitted from either the neck strap probe or from the hand piece, or from both.
Laser procedure
Patients were placed in a supine position. For the first 10 minutes, proximal priority treatment using the neck strap probe was performed. Proximal priority treatment commences at the proximal region in relation to the two centers of the nervous and circulatory systems followed by treatment of the periphery. The laser is applied solely to the nuchal area while the therapist first stretches the neck region and goes on to stretch other areas in the order of shoulder, pectoral region, spine, lower back and finally the lower limbs. The second 10 minutes is allotted for local (abdominal-lumbar area) treatment for the stimulation of the reproductive organs (Fig. 2 ).
Patients and method
Eight hundred and fourteen patients presented at the Ohshiro clinic for treatment of infertility from July 1 st , 2000 till December, 2009. Two hundred and twenty-six patients were excluded from this study due to discontinuation of treatment after learning about the treatment or as a result of the clinical examination. The other 588 patients were enrolled in the analysis. In 588 patients, 97 patients became pregnant and 491 patient dids not become pregnant (Table 1) . We checked the normal distribution and homogeneity of variance between the age of the pregnant and non-pregnant women. We analyzed the age, the infertility treatment The small probe attached to the coiled cable is the neck irradiator. The probe is placed somewhere along the posterior portion of the neck. The conventional hand held probe is located in its storage compartment on the right. Table 1 . Number of patients term, the therapeutic frequency and the therapeutic period (the number of menstrual cycle) between pregnant women and non-pregnant women. Results were expressed as mean ± standard error of mean. The statistical difference was determined by the two-side Student's t-test and the Mann-Whitney U test. Differences with a value of P < 0.05 were considered significant. Regarding the therapeutic frequency and the therapeutic period, we compared the data among women who failed to become pregnant (non-pregnant women), women who miscarried (miscarriage women) and women who successfully gave birth (childbirth women).
Result
There was no significant difference as determined with the two-sided Student's t-test in the normal distribution and homogeneity of variance between pregnant and non-pregnant women age (Fig. 3) . The mean age of pregnant women was 37.8 ±4.5 years old. The mean age of non-pregnant women was 39.8±4.8 years old. The mean infertility treatment term for pregnant women was 3.6±2.4 years and was 4.4±3.5 years for non-pregnant women. The statistical difference was determined by Mann-Whitney's U test. The mean therapeutic frequency in pregnant women was 3.1±1.4 times, and was 2.6±1.3 times in non pregnant women. The statistical difference was determined by MannWhitney's U test. The mean therapeutic period in pregnant women was 5.3±5.5 periods, and was 4.9±4.5 periods in nonpregnant women. There was no significant difference ( Table 2) There was no significant difference in the normal distribution and homogeneity of variance between the ages of pregnant and non-pregnant women. 
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women and childbirth women. In contrast, the therapeutic period was almost the same (Table 3) .
Discussion
The primary cause for female fertility declining with age is the gradual disappearance of oocytes from the oocyte stock that is formed during fetal development.
2) The age-related decline in female fertility is not only due to a declining follicle pool, but is also the result of a decline in oocyte quality. Development of follicles from the smallest primordial and primary follicles to the largest preovulatory follicles requires different stimulatory and survival factors that are stage-dependent (Fig. 4). 3) Systemic blood flow decreases as women grow older. Sore shoulders and coldness of the tips of the extremities are common symptoms seen in older women. Decrease of systemic blood flow and flow to the ovaries might cause the degradation of follicle development and lead to poor oocyte quality because blood-borne trophic and nutritive factors could not reach the developing follicles. Furthermore, meiotic division errors, mitochondrial DNA mutations and aging itself have also been suggested to play a part in the age-associated reduction in oocyte quality. 4) Older women seem to have more mitochondrial DNA mutations, which can be responsible for poor implantation and aneuploidy. 5) Mitochondrial activation is one of the reported beneficial effects of LLLT. 6) Systemic blood flow increase and the LLLT-mediated mitochondrial activation might contribute to the favorable response to ART and increase the probability of pregnancy.
The LLLT-mediated effect of increased blood flow has been reported as lasting for 3-4 days at least, 7) but could not last more than 2 weeks. From this time analysis, successful results could be obtained by more than 3.3 treatment sessions per month. The therapeutic interval was 9.1-9.4 days. This interval might match the period for which the LLLT-mediated effect could last, so we recommend that patients receive LLLT every week, which definitely corresponds to the period for which the LLLT-mediated effect remains latent.
Development of follicles from the smallest primordial and primary follicles to the largest preovulatory follicles takes 5-6 menstrual periods. From this time analysis, we could possibly help to achieve a successful result by treating the patient for more than 5 menstrual periods, which correspond to the whole oogenesis period. The optimal LLLT treatment period to become pregnant might thus be more than 5 menstrual periods.
Finally it has been clear that fertility declines dramatically as women age beyond their mid-thirties. Nikolaou reported the average pregnancy rate following IVF fell from 50% for women aged less than 35 to 28% in the 35-38 age group, 18% in the 38-39 group and 12% in the 40-42 group. 8) From this time analysis, women who are under 38 years old women have an advantage as far as getting a successful result is concerned. To start LLLT in females below 38 years old and in their early infertility treatment term is important to achieve pregnancy.
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